Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/29/2003 | EP1355946A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
10/29/2003 | EP1355924A2 Armed peptides |
10/29/2003 | EP1355910A1 Formulation of boronic acid compounds |
10/29/2003 | EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives |
10/29/2003 | EP1355682A2 Hydrogel wound dressing and the method of making and using the same |
10/29/2003 | EP1355670A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers |
10/29/2003 | EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
10/29/2003 | EP1355664A2 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
10/29/2003 | EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis |
10/29/2003 | EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate |
10/29/2003 | EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
10/29/2003 | EP1355647A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
10/29/2003 | EP1355636A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
10/29/2003 | EP1355635A1 New film coating |
10/29/2003 | EP1355634A2 Sn-38 lipid complexes and methods of use |
10/29/2003 | EP1355633A1 New film coating |
10/29/2003 | EP1355632A1 Amlodipine free base |
10/29/2003 | EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
10/29/2003 | EP1355630A2 Method of forming microparticles |
10/29/2003 | EP1355629A1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids |
10/29/2003 | EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery |
10/29/2003 | EP1355627A1 Block-structure copolymer consisting of a saccharide segment bound to at least a biodegradable hydrophobic segment, and corresponding particles |
10/29/2003 | EP1355626A2 Veterinary dermatologic composition |
10/29/2003 | EP1355610A1 Device for inserting a needle-shaped body into living tissue |
10/29/2003 | EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
10/29/2003 | EP1355537A1 Production of capsules and particles for improvement of food products |
10/29/2003 | EP1251853B1 Transdermal therapeutic system for the administration of zaleplon |
10/29/2003 | EP1214056B1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
10/29/2003 | EP1204429B1 Sustained release formulation of a peptide |
10/29/2003 | EP1161230B1 Transdermal therapy system and method for producing the same |
10/29/2003 | EP1105096B1 Injectable aqueous dispersions of propofol |
10/29/2003 | EP1028714B1 Vitamin composition |
10/29/2003 | EP1017370B1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
10/29/2003 | EP0968000B1 Administrable compositions and methods for magnetic resonance imaging |
10/29/2003 | EP0941066B1 Cationic lipid-nucleic acid complexes |
10/29/2003 | EP0921787B1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS |
10/29/2003 | EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
10/29/2003 | EP0732920B1 Therapeutic agents containing thyroid hormones |
10/29/2003 | EP0594803B1 Composition for reducing side-effects of a drug |
10/29/2003 | CN2582603Y Special-shaped tablet |
10/29/2003 | CN2582602Y Chinese medicine plaster film |
10/29/2003 | CN1452650A Process for preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
10/29/2003 | CN1452617A Acid-sensitive compounds, preparation and uses thereof |
10/29/2003 | CN1452613A Amorphous torasemide modification |
10/29/2003 | CN1452493A Method for cell adhesion and wound healing |
10/29/2003 | CN1452485A Cannabinoid drugs |
10/29/2003 | CN1452481A Pectin film compositions |
10/29/2003 | CN1452480A Granular preparations for oral administration |
10/29/2003 | CN1452479A Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
10/29/2003 | CN1452478A Pre-formed sheet devices suitable for topical application |
10/29/2003 | CN1451443A Composition using bio-absorbable liquid polymer and medical apparatus |
10/29/2003 | CN1451438A Sparagin injection using xylitol as isosmotic adjusting agent |
10/29/2003 | CN1451433A Shenji ointment and preparing process thereof |
10/29/2003 | CN1451428A Cough and asthma emplastrum |
10/29/2003 | CN1451424A Preparation of catechu suppository |
10/29/2003 | CN1451422A Chinese medicine for treating fundus oculi bleeding |
10/29/2003 | CN1451421A ÔÇ£GukangÔÇØ patch |
10/29/2003 | CN1451412A Refreshing tobacco and mustard chewing tablet |
10/29/2003 | CN1451407A Process for producing Chinese medicine cell wall-broken micro powder |
10/29/2003 | CN1451399A Superfine gastrodia tuber and American ginseng powder buccal lozenge |
10/29/2003 | CN1451394A Superfine pearl powder and producing process thereof |
10/29/2003 | CN1451386A Rifaximin soft capsule composition |
10/29/2003 | CN1451382A Medicine for treating senile dementia and preparing process thereof |
10/29/2003 | CN1451380A Percutaneous tobuterol patch |
10/29/2003 | CN1451375A Pulse plug capsule for treating circabian rhythm disease and preparing process thereof |
10/29/2003 | CN1451374A Double-layer slow release ibuprofen and pseudoephedrine hydrochloride tablet |
10/29/2003 | CN1451373A Insoluble medicine tablet and preparing process thereof |
10/29/2003 | CN1451372A Method for preparing medicine targeted liposome |
10/29/2003 | CN1125654C Methods of preparing gas and gaseous precursor filled microspheres |
10/29/2003 | CN1125653C Pharmaceutical formulations containing voriconazole |
10/29/2003 | CN1125652C Wu Zuze |
10/29/2003 | CN1125648C Patch for giving out smoking and its preparing process |
10/29/2003 | CN1125640C Prophylactic and therapeutic agent for inflammatory intestinal diseases |
10/29/2003 | CN1125639C Paroxetine Compsns |
10/29/2003 | CN1125638C Stable slow release vitamin C preparation and its production process |
10/29/2003 | CN1125636C Process for preparing particles containing oral 'beta' lactam activity |
10/29/2003 | CN1125635C Enrofloxacine injection or infusion solutions |
10/28/2003 | US6639113 Dispersing in an aqueous protecting colloids comprising at least one partially hydrolyzed soybean protein, drying by dehydration and desolventizing; use as additive to foods, pharmaceuticals and/or animal feeds |
10/28/2003 | US6639105 For inhibiting tumor cell growth |
10/28/2003 | US6639014 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
10/28/2003 | US6638994 Aqueous suspension of nanoparticles comprising an agrochemical active ingredient |
10/28/2003 | US6638987 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
10/28/2003 | US6638981 Topical compositions and methods for treating pain |
10/28/2003 | US6638971 Cocoa extract compounds and methods for making and using the same |
10/28/2003 | US6638948 A free-flowing, amorphous paroxetine hydrochloride composition suitable as a therapeutic agent for premature ejaculation can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by |
10/28/2003 | US6638932 Derivatives having HIV replication inhibiting properties. The present compounds differ from the known 1,3,5-triazines by structure and by their improved HIV replication inhibiting properties. |
10/28/2003 | US6638918 Chitosan compositions |
10/28/2003 | US6638915 Anti-viral composition |
10/28/2003 | US6638913 Concentrated injection and infusion solution for intravenous administration |
10/28/2003 | US6638767 Methods for delivering compounds into a cell |
10/28/2003 | US6638740 Chromatography, elution, ion exchanging |
10/28/2003 | US6638727 Intraductally administering an estrogen activity modulator |
10/28/2003 | US6638621 Coated particles, methods of making and using |
10/28/2003 | US6638613 Therapeutically enhanced saliva-activatable cellulosic product |
10/28/2003 | US6638550 Method for coating solid confectionery centers |
10/28/2003 | US6638540 Plant extracts for the treatment of increased bone resorption |
10/28/2003 | US6638537 Emulsification with a long chain polymer surfactant and a short chain fatty acid surfactant; thermodynamic stability |
10/28/2003 | US6638536 Storage stable allotropic organic compounds; sustained release, bioavailability, solid state crystallized |
10/28/2003 | US6638535 Modified release formulations containing a hypnotic agent |
10/28/2003 | US6638534 Preparation capable of releasing drug at target site in intestine |